These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22125973)

  • 1. Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.
    Bubela T; Morin JF
    Health Law J; 2010; 18():113-57. PubMed ID: 22125973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reforming Canada's Access to Medicines Regime.
    Elliott R
    CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
    [No Abstract]   [Full Text] [Related]  

  • 4. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B; Thangaraj H
    Pharm Pat Anal; 2013 Mar; 2(2):195-213. PubMed ID: 24237026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.
    Esmail LC; Kohler JC
    Global Health; 2012 Apr; 8():7. PubMed ID: 22472291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
    Kuek V; Phillips K; Kohler JC
    Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removing barriers? An overview of the Canadian Access to Medicines Regime.
    Penner MD; Armstrong PG
    Health Law Can; 2008 Jun; 28(3-4):112-22. PubMed ID: 19051971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reforming Canada's Access to Medicines Regime.
    Esmail LC
    CMAJ; 2007 Jul; 177(3):270. PubMed ID: 17664454
    [No Abstract]   [Full Text] [Related]  

  • 9. Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?
    Cohen-Kohler JC; Esmail LC; Cosio AP
    Global Health; 2007 Dec; 3():12. PubMed ID: 18062821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International assistance and cooperation for access to essential medicines.
    Mok EA
    Health Hum Rights; 2010 Jun; 12(1):73-81. PubMed ID: 20930255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canada and access to medicines in developing countries: intellectual property rights first.
    Lexchin J
    Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding GOs and NGOs.
    Divinagracia ER
    Integration; 1997; (54):34-9. PubMed ID: 12293675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond idealism and realism: Canadian NGO/government relations during the negotiation of the FCTC.
    Lencucha R; Labonté R; Rouse MJ
    J Public Health Policy; 2010 Apr; 31(1):74-87. PubMed ID: 20200527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-governmental organizations in international health: past successes, future challenges.
    Gellert GA
    Int J Health Plann Manage; 1996; 11(1):19-31. PubMed ID: 10157062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.
    Esmail LC; Phillips K; Kuek V; Cosio AP; Kohler JC
    BMC Int Health Hum Rights; 2010 Jan; 10():1. PubMed ID: 20044940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Working with NGOs: PAHO's approach.
    Hartigan P; Wiseman T
    Glob AIDSnews; 1993; (3):17-8. PubMed ID: 12287374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime.
    Elliott R
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):23-5. PubMed ID: 18459195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.